MedPath

t-PA trial for central retinal artery occlusio

Not Applicable
Recruiting
Conditions
central retinal artery occlusion
artery occlusion
H341
Registration Number
JPRN-jRCTs041190079
Lead Sponsor
Hayashi Atsushi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

1.Patients older than 20
2.Diagnosed with central retinal artery occulusion within 24 hours
3.Treated with pars plana vitrectomy as an inpatient in this research facility
4.No history of cerebrovascular disease such as stroke,
and judged that drug used in this research is not deterioration factor
5.Obtain written informed consent

Exclusion Criteria

1.Expected that the drug influence previous disease
2.central retinal artery occlusion more than 24 hours after the onset
3.Pregnant, possibile pregnancy or hope for pregnancy during the study period

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual acuity at 12 weeks after the first operation
Secondary Outcome Measures
NameTimeMethod
Changes in visual acuity and central retinal thickness at 12 weeks after the first operation
© Copyright 2025. All Rights Reserved by MedPath